About Neovasc (TSE:NVC)
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Industry, Sector and Symbol:
- Industry: N/A
- Sub-Industry: N/A
- Sector: N/A
- Symbol: TSE:NVC
- CUSIP: N/A
- Web: www.neovasc.com
- Trailing EPS: C($0.08)
- Net Margins: -409.25%
- Return on Assets: -23.96%
- Outstanding Shares: 78,683,000
Frequently Asked Questions for Neovasc (TSE:NVC)
What is Neovasc's stock symbol?
Neovasc trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NVC."
When will Neovasc make its next earnings announcement?
Who are some of Neovasc's key competitors?
Some companies that are related to Neovasc include Pine Cliff Energy (PNE), TVA Group (TVA.B), Alexco Resource Corp. (AXR), Stuart Olson (SOX), Xtreme Drilling Corp. (XDC), Gear Energy (GXE), NewCastle Gold Ltd (NCA), Freshii (FRII), North American Energy Partners (NOA), CENTRIC HEALTH Corp (CHH), Ecosynthetix (ECO), Gabriel Resources Ltd (GBU), TransGlobe Energy (TGL), Mandalay Resources (MND), Nautilus Minerals (NUS), PHX Energy Services Corp (PHX), KP Tissue (KPT) and Bellatrix Exploration Ltd (BXE).
Who are Neovasc's key executives?
Neovasc's management team includes the folowing people:
- Paul L. Geyer, Independent Chairman of the Board
- Alexei J. Marko, Chief Executive Officer, Director
- Christopher Clark, Chief Financial Officer, Corporate Secretary
- Brian McPherson, Chief Operating Officer
- Vicki Lee Bebeau, Vice President - Clinical Affairs
- Randy Lane, Vice President - Research & Development
- Jane H. Hsiao Ph.D., Independent Director (Age 69)
- Douglas Glen Janzen, Independent Director
- William O'Neill, Independent Director (Age 61)
- Steven D. Rubin Esq. J.D., Independent Director (Age 56)
How do I buy Neovasc stock?
Shares of Neovasc and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Neovasc's stock price today?
One share of Neovasc stock can currently be purchased for approximately C$1.78.
How big of a company is Neovasc?
Neovasc has a market capitalization of C$86.77 million.
How can I contact Neovasc?
Neovasc's mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The company can be reached via phone at +1-604-2704344.
MarketBeat Community Rating for Neovasc (NVC)MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Neovasc (TSE:NVC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Neovasc (TSE:NVC)
Analysts' Ratings History for Neovasc (TSE:NVC)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Neovasc (TSE:NVC)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Neovasc (TSE:NVC)
2017 EPS Consensus Estimate: ($0.06)
2018 EPS Consensus Estimate: $0.00
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Neovasc (TSE:NVC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Neovasc (TSE NVC)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for Neovasc (TSE NVC)
Financials are not available for this stock.
Neovasc (TSE NVC) Chart for Wednesday, November, 22, 2017